It mimics the naturally occurring GLP-1 hormone, helping regulate appetite and improve blood sugar control
The study also: Compared tirzepatide with phentermine rather than placebo Identified pain through diagnosis and prescription records Did not directly measure each patients pain severity Could not fully separate the effects of weight loss from medication-specific effects Could not prove that tirzepatide caused the reduction in pain encounters The findings support further research, but they are not enough to classify tirzepatide as a joint-pain or arthritis medication
Being overweight is linked to fertility problems like implantation issues and miscarriages
This article aims to provide a comprehensive overview of the role of Gln transporters in DSMTs, along with an exploration of targeted therapeutic drugs, with the goal of providing valuable insights into the drug discovery process for DSMTs therapy and deepening our understanding of the underlying mechanisms
Regular monitoring prevents levels from exceeding target ranges
Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China 7